Low-Dose Naltrexone Use in Pain Reduction for Dysautonomia Patients: A Case Series (P3-7.002)

In this study, we evaluated the efficacy of low-dose naltrexone (LDN) among a patient population diagnosed with generalized autonomic dysfunction.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000210647
Primary Topic
Botulinum Toxin and Related Neurological Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Low-Dose Naltrexone Use in Pain Reduction for Dysautonomia Patients: A Case Series (P3-7.002)

C. A. Cantrell, Robert Wilson, Emily Georgiadi, Nicholas Zapata
Neurology
Botulinum Toxin and Related Neurological Disorders
article

Low-Dose Naltrexone Use in Pain Reduction for Dysautonomia Patients: A Case Series (P3-7.002)

C. A. Cantrell, Robert Wilson, Emily Georgiadi, Nicholas Zapata
article en

Abstract

In this study, we evaluated the efficacy of low-dose naltrexone (LDN) among a patient population diagnosed with generalized autonomic dysfunction.

NeurologyVol. 104(7_Supplement_1)
Cleveland Clinic (US), The Ohio State University (US)
Zero hunger
Openalex Percentile: Top 89%
Botulinum Toxin and Related Neurological Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Low-Dose Naltrexone Use in Pain Reduction for Dysautonomia Patients: A Case Series (P3-7.002) — C. A. Cantrell, Robert Wilson, et al. · Neurology (2025) | TGRS Research Map | TGRS